Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $129.28 | 9 | 91.6% |
| Education | $11.92 | 1 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $26.17 | 2 | $0 (2017) |
| Celgene Corporation | $19.62 | 1 | $0 (2017) |
| Novocure Inc. | $15.81 | 1 | $0 (2018) |
| Millennium Pharmaceuticals, Inc. | $15.31 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $14.56 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $13.83 | 1 | $0 (2017) |
| Helsinn Therapeutics (U.S.), Inc. | $12.83 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $11.15 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2018 | $15.81 | 1 | Novocure Inc. ($15.81) |
| 2017 | $113.47 | 8 | Lilly USA, LLC ($26.17) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 10/17/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $15.81 | General |
| Category: Optune | ||||||
| 12/20/2017 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Oncology | ||||||
| 11/09/2017 | Helsinn Therapeutics (U.S.), Inc. | ALOXI (Drug), ZYKADIA, AKYNZEO | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2017 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2017 | Otsuka America Pharmaceutical, Inc. | SPRYCEL (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: HEMATOLOGY | ||||||
| 07/20/2017 | Millennium Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 05/04/2017 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, LARTRUVO | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Oncology | ||||||
| 03/09/2017 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, LARTRUVO | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Oncology | ||||||
| 01/18/2017 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 188 | 351 | $40,943 | $24,320 |
| 2022 | 6 | 189 | 356 | $52,816 | $24,691 |
| 2021 | 7 | 279 | 604 | $78,305 | $43,761 |
| 2020 | 8 | 267 | 646 | $76,383 | $38,776 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 79 | 195 | $23,345 | $13,835 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 74 | 110 | $8,904 | $5,016 | 56.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 31 | $5,709 | $3,359 | 58.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $2,985 | $2,109 | 70.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 84 | 199 | $24,496 | $14,286 | 58.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 54 | 69 | $7,412 | $3,071 | 41.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 28 | $8,680 | $2,206 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 16 | $2,688 | $1,815 | 67.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 32 | $7,200 | $1,752 | 24.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $2,340 | $1,561 | 66.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 126 | 371 | $38,692 | $27,637 | 71.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 54 | $16,470 | $4,386 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 64 | 85 | $6,902 | $4,044 | 58.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 19 | 27 | $4,390 | $3,067 | 69.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 38 | $8,246 | $2,146 | 26.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $2,057 | $1,517 | 73.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 16 | 18 | $1,548 | $962.64 | 62.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 119 | 438 | $43,530 | $26,771 | 61.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 23 | 32 | $9,344 | $2,643 | 28.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 45 | 70 | $6,645 | $2,539 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 40 | $8,400 | $2,312 | 27.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 17 | 23 | $3,278 | $1,918 | 58.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 11 | 11 | $2,222 | $1,482 | 66.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 17 | 20 | $1,584 | $735.50 | 46.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 12 | $1,380 | $375.21 | 27.2% |
About Dr. Anna Perelshteyn, M.D
Dr. Anna Perelshteyn, M.D is a Hematology & Oncology healthcare provider based in Duluth, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1659699536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Perelshteyn, M.D has received a total of $141.20 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 10 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($129.28).
As a Medicare-enrolled provider, Perelshteyn has provided services to 923 Medicare beneficiaries, totaling 1,957 services with total Medicare billing of $131,546. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Duluth, MN
- Active Since 05/17/2010
- Last Updated 02/21/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659699536
Products in Payments
- ALIMTA (Drug) $26.17
- Abraxane (Drug) $19.62
- Oncology (Device) $15.81
- SPRYCEL (Drug) $14.56
- CALQUENCE (Drug) $13.83
- ALOXI (Drug) $12.83
- KISQALI (Drug) $11.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Duluth
Julia Baker, D.o, D.O
Hematology & Oncology — Payments: $90,759
Mr. Jesus Vera Aguilera, M.d, M.D
Hematology & Oncology — Payments: $8,098
Dr. Roberto Fernandez, D.o. Mph, D.O. MPH
Hematology & Oncology — Payments: $598.74
Joseph Levine, Md, MD
Hematology & Oncology — Payments: $392.49
Venkata Pokuri, Md, MD
Hematology & Oncology — Payments: $167.72
Hannah Jarnagin
Hematology & Oncology — Payments: $80.25